Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    3046553 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)
Condition: Schizophrenia
Interventions: Device: Venous blod sample;   Device: CHEMPAQ
2 Completed Switching Antipsychotics: Abrupt Discontinuation Versus Overlap
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention: Drug: Clozapine

Study has passed its completion date and status has not been verified in more than two years.